We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MERCK GETS ANTITRUST CLEARANCE FOR ATON PHARMA ACQUISITION
MERCK GETS ANTITRUST CLEARANCE FOR ATON PHARMA ACQUISITION
March 12, 2004
Federal regulators have approved Merck’s acquisition of privately held biotech company Aton Pharma, clearing the way for Merck to re-enter the cancer drug market after a 34-year hiatus.